Khur Lite

Terms of Service

Last Updated: June 17, 2026

Terms of Service

Last Updated: 2026-06-17

These Terms of Service ("Terms") form a legally binding agreement between you ("User") and LVIM Ltd, a company registered in England and Wales (Companies House no. 16842316, "Company", "we", "us", "our"), governing your use of the Khur Lite mobile application ("Application").

By downloading, installing, or using the Application, you confirm that you have read, understood, and agree to be bound by these Terms. If you do not agree, do not use the Application.

1. Description of Service

Khur Lite is a mobile application that helps patients with rare diseases, their caregivers, and medical professionals discover, track, and make contact with clinical trials listed on ClinicalTrials.gov. The Application provides search, filtering, push notification alerts for new or updated trials, and tools to organise trials you have contacted.

Khur Lite is an information and discovery tool only. It is not a medical service, a clinical platform, or a regulated medical device.

2. Not Medical Advice

THE APPLICATION, INCLUDING ALL CONTENT, TRIAL LISTINGS, SEARCH RESULTS, MATCH SCORES, AND NOTIFICATIONS, IS PROVIDED FOR INFORMATIONAL AND GENERAL WELLNESS PURPOSES ONLY. NOTHING IN THIS APPLICATION CONSTITUTES PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS, TREATMENT, OR CLINICAL RECOMMENDATION.

  • Your use of the Application does not create a doctor-patient relationship or any other healthcare professional relationship between you and the Company.
  • Always consult a qualified healthcare professional before making any medical decisions, starting or stopping treatment, or acting on trial information found in this Application.
  • Clinical trial eligibility is determined solely by the trial sponsor and the treating physician — not by this Application.
  • In a medical emergency, contact emergency services immediately. This Application is not for emergency use.

Khur Lite is not a regulated medical device under the EU Medical Devices Regulation (MDR), the UK Medical Device Regulations 2002, the US FDA 21 CFR Part 820, or equivalent frameworks in any jurisdiction. It does not diagnose, prevent, monitor, or treat any disease or condition.

3. Eligibility

  • You must be at least 18 years old to create an account and use the Application independently.
  • Users aged 13–17 may use the Application only under the direct supervision of a parent or legal guardian who accepts these Terms on their behalf, in the context of tracking a clinical condition.
  • The Application is not intended for use by children under 13.
  • By using the Application, you confirm that you meet the eligibility requirements above.

4. Account Types and User Roles

4.1 Account Types

The Application supports two account modes:

  • Guest (Unregistered): When you use the App without creating a registered account, a unique identifier (UID) is created to manage your notification subscriptions and device settings. This UID and a pseudonymous diagnosis (MeSH code) are stored on our servers to ensure your trial alerts are delivered correctly. This data is not linked to any personally identifiable information like your name or email. Anonymous sessions cannot be restored across devices — signing out permanently ends the session and a new anonymous UID will be created on next launch.
  • Registered (Email / Sign in with Apple): You create an account with an email address or by using Sign in with Apple. Your subscription plan, language preference, pseudonymous diagnosis, and consent records are stored on our servers.

4.2 User Roles

Currently, the App is optimised for Patients and Caregivers.

  • Patient / Caregiver: Individuals tracking trials for personal or family use.
  • Professional (Post-MVP): Features for clinical researchers and healthcare professionals are currently under development and may not be fully available. Same data handling as Registered account.

You are responsible for maintaining the confidentiality of your account credentials and for all activity that occurs under your account.

5. Subscription Plans and Billing

The Application offers free and paid subscription tiers. Paid tiers are processed exclusively through Apple/Google's in-app purchase systems.

  • Payment: Charges are applied to your app store account at confirmation of purchase.
  • Auto-Renewal: Subscriptions renew automatically unless cancelled at least 24 hours before the end of the current billing period.
  • Cancellation: Manage or cancel your subscription at any time via your app store account settings. The Company cannot cancel or refund in-app purchases on your behalf.
  • Free Trials: Any unused portion of a free trial period is forfeited upon purchase of a paid subscription.
  • Price Changes: The app store may notify you of price changes before your next renewal. Continued use after a price change constitutes acceptance.
  • Account Deletion: You may delete your account and all associated data at any time via the Application. Account deletion removes all data and active subscriptions handled by us from our systems, except records we are required to retain for legal compliance (for example, consent records — see the Privacy Policy).

6. Acceptable Use

You agree not to:

  • Use the Application for any unlawful purpose or in violation of these Terms.
  • Attempt to reverse engineer, decompile, or extract the source code of the Application.
  • Use automated tools, bots, or scripts to scrape trial data from the Application or from ClinicalTrials.gov through the Application.
  • Misrepresent your identity, qualifications, or eligibility when contacting trial researchers.
  • Upload, transmit, or distribute any content that is harmful, fraudulent, or violates third-party rights.
  • Use the Application in any jurisdiction where its use is prohibited by local law.

7. Clinical Trial Contact Guidelines

The Application may provide contact information or communication tools related to clinical trials. When contacting trial researchers or coordinators:

  • Provide accurate information about yourself or the patient you represent.
  • Do not contact trial teams repeatedly, abusively, or for purposes unrelated to genuine trial interest.
  • Understand that contacting a trial team does not guarantee eligibility or enrolment.
  • The Company is not responsible for the outcome of any contact made with trial researchers.

8. Intellectual Property

All content, design, software, and trademarks within the Application are the property of the Company or its licensors and are protected by applicable intellectual property laws. You are granted a limited, non-exclusive, non-transferable licence to use the Application for personal, non-commercial purposes only.

Clinical trial data displayed in the Application is sourced from ClinicalTrials.gov, a public database maintained by the US National Library of Medicine. This data is in the public domain. The study sponsor or principal investigator is responsible for the completeness and accuracy of individual trial records; LVIM Ltd does not review, verify, or endorse individual study content.

9. Export Controls and Sanctions Compliance

By using the Application, you represent and warrant that:

  • You are not located in, or a national of, a country or region subject to comprehensive US OFAC sanctions (including Cuba, Iran, North Korea, Syria, Russia, and the Crimea, Donetsk, and Luhansk regions of Ukraine).
  • You are not listed on the OFAC Specially Designated Nationals list or any equivalent restricted-party list.
  • Your use of the Application complies with all applicable local laws.

10. Disclaimer of Warranties

THE APPLICATION IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. WE DO NOT WARRANT THAT THE APPLICATION WILL BE UNINTERRUPTED, ERROR-FREE, OR FREE OF VIRUSES. TRIAL DATA IS SOURCED FROM THIRD PARTIES AND MAY BE INCOMPLETE OR OUT OF DATE.

11. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE COMPANY SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING LOSS OF DATA, LOSS OF PROFITS, PERSONAL INJURY, OR WRONGFUL DEATH, ARISING FROM YOUR USE OF OR INABILITY TO USE THE APPLICATION.

Our total liability to you for any claim arising from these Terms or your use of the Application shall not exceed the amount you paid to the Company (excluding app store fees) in the twelve months preceding the claim, or £100, whichever is greater.

Nothing in these Terms limits liability for death or personal injury caused by our negligence, fraud, or fraudulent misrepresentation, or any other liability that cannot be excluded under applicable law.

12. Indemnification

You agree to indemnify and hold harmless the Company and its officers, directors, employees, and agents from any claims, damages, losses, and expenses (including reasonable legal fees) arising from your use of the Application, your violation of these Terms, or your contact with clinical trial teams.

13. Governing Law and Dispute Resolution

These Terms are governed by the laws of England and Wales. Any disputes arising from these Terms or the Application shall be subject to the exclusive jurisdiction of the courts of England and Wales.

If you are a consumer resident in another jurisdiction, you may also have rights under your local consumer protection laws that cannot be waived by this clause. Nothing in these Terms affects those rights.

14. Governing Language

These Terms are drafted in the English language. If the Application does not support your preferred local language and defaults to English, or if you use third-party tools to translate these Terms, you acknowledge and agree that you are bound by this English version. In the event of any conflict or inconsistency between the English version of these Terms and any translated version, the English version shall exclusively govern and control.

15. Changes to These Terms

We may update these Terms from time to time. When we do, we will update the "Last Updated" date and, for material changes, notify you via an in-app prompt on your next launch. Continued use of the Application after the updated Terms take effect constitutes your acceptance.

16. Contact

LVIM Ltd London, United Kingdom Email: team@lvim.io